Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.78 USD | +6.25% | +3.84% | -8.13% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |